Skip to content

Neoflon

by Becton Dickinson Infusion Therapy Systems Inc. 4 variants

Ref 391379

Active European Union

CE MDR

Valid until

Not listed

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number038290ZCNOSRXLMV Basic UDI-DI 00382903913794UDI-DIDate29 Apr 2026RegisteredStatusActive

Certificates

0 certificates · EUDAMED

EUDAMED lists no certificate for this device's Basic UDI-DI.

A certificate issued for a device group may exist without being linked here.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
BD Neoflon™ Pro IV Cannula
Model / Reference
391379
Primary DI / UDI-DI
00382903913794
Basic UDI-DI
038290ZCNOSRXLMV
EMDN Code
C0101010101 Peripheral i.v. catheters, w/o safety systems, with injection valves
Device Class
Class IIa
EU market of registration
Slovenia

Manufacturer details

EUDAMED SRN
US-MF-000017719
Authorised representative
Becton Dickinson Ireland Limited IE-AR-000007610

Other devices from Becton Dickinson Infusion Therapy Systems Inc.

See all devices from Becton Dickinson Infusion Therapy Systems Inc. →

Properties

  • Sterile
  • CMR Substance
  • Animal Tissues
  • Administering Medicine

Other properties (9)

  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • Human-derived: No
  • Human Tissues: No
  • Endocrine Disruptor: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No